Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1970779

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1970779

Gynecomastia Procedures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Age Group, By Procedure Type, By End-Use, By Region & Competition, 2021-2031F

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Gynecomastia Procedures Market is projected to expand from a valuation of USD 0.18 Billion in 2025 to USD 0.29 Billion by 2031, reflecting a CAGR of 8.54%. These procedures entail the surgical reduction of excess glandular or fatty breast tissue in men, aiming to restore a flatter and more masculine chest profile. Key drivers propelling this market include broader societal acceptance of male aesthetic treatments and an intensified focus on physical appearance and mental well-being. Additionally, the rising prevalence of hormonal imbalances caused by medication use and lifestyle factors continues to fuel consistent demand for corrective interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 0.18 Billion
Market Size 2031USD 0.29 Billion
CAGR 2026-20318.54%
Fastest Growing SegmentAbove 40 years
Largest MarketNorth America

According to the International Society of Aesthetic Plastic Surgery, 352,302 gynecomastia procedures were performed globally in 2023. Despite this substantial volume, the market encounters a significant obstacle regarding insurance reimbursement policies. Most healthcare providers categorize this surgery as a cosmetic enhancement rather than a medical necessity, leading to steep out-of-pocket costs that restrict patient access and hinder overall market expansion.

Market Driver

The increasing influence of social media and celebrity culture on male beauty standards acts as a primary catalyst for the global gynecomastia procedures market. Men are frequently exposed to digital content that glorifies a sculpted, "V-taper" physique, which fosters critical self-assessment of chest contours and fuels the desire for surgical correction of overdeveloped tissue. This cultural shift has destigmatized male cosmetic interventions, prompting a broader demographic to pursue professional treatment for aesthetic improvements rather than solely medical reasons. Consequently, procedure volumes remain robust nationally, with The Aesthetic Society reporting in June 2024 that gynecomastia treatment became the second most popular surgical procedure for men in the U.S. during 2023, totaling 21,043 operations.

Simultaneously, rising disposable incomes and a willingness to spend on elective medical treatments are sustaining market value. Although most insurance policies classify male breast reduction as cosmetic, forcing patients to bear the full financial burden, the sector continues to thrive despite these economic barriers. This trend is reflected in escalating surgical costs, which signal both inflationary pressures and the premium consumers place on specialized results; for instance, the American Society of Plastic Surgeons noted in June 2024 that the average surgeon fee for this procedure rose to $5,587. This investment in aesthetic improvement mirrors broader industry resilience, as evidenced by The Aesthetic Society's 2024 report showing a 2.9 percent year-over-year increase in total surgical volume.

Market Challenge

A major barrier to the growth of the global market is the classification of gynecomastia surgery as a cosmetic enhancement by the majority of insurance providers. Since healthcare payers often deem this procedure not medically necessary, coverage applications are frequently denied, forcing patients to assume the full financial liability. This burden encompasses not only the surgeon's fee but also facility and anesthesia costs, creating a high economic threshold that effectively excludes a significant portion of the addressable population who suffer from the condition but cannot afford elective surgery.

Consequently, this restrictive reimbursement landscape severely limits the conversion of high patient interest into actual surgical volume. Despite the increasing incidence of the condition and greater social acceptance, the market struggles to expand rapidly as financial constraints hamper accessibility. Data from the American Society of Plastic Surgeons highlights this issue, reporting that gynecomastia reduction procedures increased by only 2% in 2024. This marginal growth rate clearly indicates that the lack of insurance support is stifling market momentum and preventing the industry from fully realizing the underlying demand.

Market Trends

The operational landscape of the gynecomastia market is being reshaped by a shift in surgical volumes from traditional hospitals to specialized ambulatory centers. This transition is largely driven by a demand for greater patient privacy and efficiency, which are crucial for the male demographic seeking discretion. Specialized facilities provide a streamlined care pathway that avoids the administrative burdens and high overhead costs of general hospitals, making the procedure more accessible while ensuring high safety standards. This preference is supported by data from The Aesthetic Society, which reported in July 2024 that 64% of all cosmetic surgical procedures in 2023 were performed in Accredited Surgical Centers, marking a distinct departure from hospital settings.

Concurrently, clinical protocols are evolving as energy-assisted liposuction technologies increasingly replace traditional excision methods. Surgeons are adopting advanced tools like radiofrequency-assisted or power-assisted lipolysis to treat glandular tissue and fat with superior precision and reduced scarring. Unlike standard scalpel-based techniques, these energy-based systems enable simultaneous fat removal and skin retraction, delivering a "shrink-wrapping" effect that appeals to patients wanting a sculpted chest without significant surgical marks. This technological adoption is driving volume growth, as demonstrated by AirSculpt Technologies' February 2024 report, which noted a 14.3% year-over-year increase in case volume attributed to their proprietary energy-based body contouring techniques.

Key Market Players

  • Allergan Aesthetics
  • Sientra
  • Cynosure
  • Cutera
  • Galderma
  • Heraeus
  • Clarion Medical
  • Mazor Robotics
  • InMode

Report Scope

In this report, the Global Gynecomastia Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gynecomastia Procedures Market, By Age Group

  • 18-40
  • Above 40

Gynecomastia Procedures Market, By Procedure Type

  • Liposuction
  • Excision

Gynecomastia Procedures Market, By End-Use

  • Hospitals
  • Cosmetic Surgery Center

Gynecomastia Procedures Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gynecomastia Procedures Market.

Available Customizations:

Global Gynecomastia Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 23881

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gynecomastia Procedures Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Age Group (18-40, Above 40)
    • 5.2.2. By Procedure Type (Liposuction, Excision)
    • 5.2.3. By End-Use (Hospitals, Cosmetic Surgery Center)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Gynecomastia Procedures Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Age Group
    • 6.2.2. By Procedure Type
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gynecomastia Procedures Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Age Group
        • 6.3.1.2.2. By Procedure Type
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Gynecomastia Procedures Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Age Group
        • 6.3.2.2.2. By Procedure Type
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Gynecomastia Procedures Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Age Group
        • 6.3.3.2.2. By Procedure Type
        • 6.3.3.2.3. By End-Use

7. Europe Gynecomastia Procedures Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Age Group
    • 7.2.2. By Procedure Type
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Gynecomastia Procedures Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Age Group
        • 7.3.1.2.2. By Procedure Type
        • 7.3.1.2.3. By End-Use
    • 7.3.2. France Gynecomastia Procedures Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Age Group
        • 7.3.2.2.2. By Procedure Type
        • 7.3.2.2.3. By End-Use
    • 7.3.3. United Kingdom Gynecomastia Procedures Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Age Group
        • 7.3.3.2.2. By Procedure Type
        • 7.3.3.2.3. By End-Use
    • 7.3.4. Italy Gynecomastia Procedures Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Age Group
        • 7.3.4.2.2. By Procedure Type
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Gynecomastia Procedures Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Age Group
        • 7.3.5.2.2. By Procedure Type
        • 7.3.5.2.3. By End-Use

8. Asia Pacific Gynecomastia Procedures Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Age Group
    • 8.2.2. By Procedure Type
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Gynecomastia Procedures Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Age Group
        • 8.3.1.2.2. By Procedure Type
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Gynecomastia Procedures Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Age Group
        • 8.3.2.2.2. By Procedure Type
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Gynecomastia Procedures Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Age Group
        • 8.3.3.2.2. By Procedure Type
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Gynecomastia Procedures Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Age Group
        • 8.3.4.2.2. By Procedure Type
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Gynecomastia Procedures Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Age Group
        • 8.3.5.2.2. By Procedure Type
        • 8.3.5.2.3. By End-Use

9. Middle East & Africa Gynecomastia Procedures Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Age Group
    • 9.2.2. By Procedure Type
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Gynecomastia Procedures Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Age Group
        • 9.3.1.2.2. By Procedure Type
        • 9.3.1.2.3. By End-Use
    • 9.3.2. UAE Gynecomastia Procedures Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Age Group
        • 9.3.2.2.2. By Procedure Type
        • 9.3.2.2.3. By End-Use
    • 9.3.3. South Africa Gynecomastia Procedures Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Age Group
        • 9.3.3.2.2. By Procedure Type
        • 9.3.3.2.3. By End-Use

10. South America Gynecomastia Procedures Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Age Group
    • 10.2.2. By Procedure Type
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gynecomastia Procedures Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Age Group
        • 10.3.1.2.2. By Procedure Type
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Colombia Gynecomastia Procedures Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Age Group
        • 10.3.2.2.2. By Procedure Type
        • 10.3.2.2.3. By End-Use
    • 10.3.3. Argentina Gynecomastia Procedures Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Age Group
        • 10.3.3.2.2. By Procedure Type
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Gynecomastia Procedures Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Allergan Aesthetics
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Sientra
  • 15.3. Cynosure
  • 15.4. Cutera
  • 15.5. Galderma
  • 15.6. Heraeus
  • 15.7. Clarion Medical
  • 15.8. Mazor Robotics
  • 15.9. InMode

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!